Sheri Volger
Overview
Explore the profile of Sheri Volger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turner D, Rosh J, Cohen S, Griffiths A, Hyams J, Kierkus J, et al.
J Pediatr Gastroenterol Nutr
. 2024 May;
79(2):315-324.
PMID: 38801079
Objectives: To assess the efficacy, safety, immunogenicity, and pharmacokinetics through 240 weeks of ustekinumab treatment in paediatric patients from the long-term extension (LTE) of the phase 1, double-blind UniStar trial....
2.
Rosh J, Turner D, Hyams J, Dubinsky M, Griffiths A, Cohen S, et al.
J Crohns Colitis
. 2024 Feb;
18(8):1250-1260.
PMID: 38408273
Background And Aims: Most paediatric inflammatory bowel disease [IBD] studies are performed after medications are approved in adults, and the majority of participants in these studies are adolescents. We hypothesised...
3.
Zhang N, Liu C, Steiner S, Colletti R, Baldassano R, Chen S, et al.
J Comp Eff Res
. 2023 Feb;
12(4):e220136.
PMID: 36799351
To evaluate the performance of the multiple imputation (MI) method for estimating clinical effectiveness in pediatric Crohn's disease in the ImproveCareNow registry; to address the analytical challenge of missing data....
4.
Adler J, Colletti R, Noonan L, Berzin T, Cheifetz A, Conklin L, et al.
Inflamm Bowel Dis
. 2022 Sep;
29(7):1089-1097.
PMID: 36049024
Background: To demonstrate treatment efficacy in Crohn's disease (CD), regulatory authorities require that trials include an endoscopic remission/response end point; however, standardized endoscopic assessment of disease activity, such as the...
5.
Volger S, Parrott J, Elbel B, John L, Block J, Rothpletz-Puglia P, et al.
Prev Med Rep
. 2022 Feb;
25:101661.
PMID: 35127348
This is the first real-world study to examine the association between a voluntary 16-ounce (oz) portion-size cap on sugar-sweetened beverages (SSB) at a sporting arena on volume of SSBs and...
6.
Volger S, Scherl E
Clin Gastroenterol Hepatol
. 2021 Apr;
20(4):962-963.
PMID: 33864935
No abstract available.
7.
Caldeo V, Downey E, OShea C, Affolter M, Volger S, Courtet-Compondu M, et al.
Clin Nutr
. 2021 Jan;
40(5):3567-3577.
PMID: 33419616
Background And Aims: The composition and enzymology of human milk changes throughout the lactation period, and differ for mothers who give birth prematurely compared to those who deliver at full-term....
8.
Vivatvakin B, Estorninos E, Lien R, Lee H, Hon K, Lebumfacil J, et al.
Glob Pediatr Health
. 2020 Oct;
7:2333794X20954332.
PMID: 33029552
Background: Signs of feeding intolerance are common in formula-fed infants. We evaluated the clinical response to a partially hydrolyzed 100% whey protein formula with high -2 palmitate and reduced lactose...
9.
Sandborn W, Feagan B, Danese S, OBrien C, Ott E, Marano C, et al.
Inflamm Bowel Dis
. 2020 Sep;
27(7):994-1007.
PMID: 32964215
Background: Ustekinumab is currently approved globally in Crohn's disease (CD) and psoriatic diseases. Recent phase 3 data demonstrate safety/efficacy in ulcerative colitis (UC). Crohn's disease and UC phase 3 programs...
10.
Freijer K, Volger S, Pitter J, Molsen-David E, Cooblall C, Evers S, et al.
Value Health
. 2019 Jan;
22(1):1-12.
PMID: 30661624
Background: The term medical nutrition (MN) refers to nutritional products used under medical supervision to manage disease- or condition-related dietary needs. Standardized MN definitions, aligned with regulatory definitions, are needed...